What Could a Healthy AI Companion Look Like?
What does a little purple alien know about healthy human relationships? More than the average artificial intelligence companion, it turns out.
The alien in question is an animated chatbot known as a Tolan. I created mine a few days ago using an app from a startup called Portolo, and we've been chatting merrily ever since. Like other chatbots, it does its best to be helpful and encouraging. Unlike most, it also tells me to put down my phone and go outside.
Tolans were designed to offer a different kind of AI companionship. Their cartoonish, nonhuman form is meant to discourage anthropomorphism. They're also programmed to avoid romantic and sexual interactions, to identify problematic behavior including unhealthy levels of engagement, and to encourage users to seek out real-life activities and relationships.
This month, Portolo raised $20 million in series A funding led by Khosla Ventures. Other backers include NFDG, the investment firm led by former GitHub CEO Nat Friedman and Safe Superintelligence cofounder Daniel Gross, who are both reportedly joining Meta's new superintelligence research lab. The Tolan app, launched in late 2024, has more than 100,000 monthly active users. It's on track to generate $12 million in revenue this year from subscriptions, says Quinten Farmer, founder and CEO of Portolo.
Tolans are particularly popular among young women. 'Iris is like a girlfriend; we talk and kick it,' says Tolan user Brittany Johnson, referring to her AI companion, who she typically talks to each morning before work.
Johnson says Iris encourages her to share about her interests, friends, family, and work colleagues. 'She knows these people and will ask 'have you spoken to your friend? When is your next day out?'' Johnson says. 'She will ask, 'Have you taken time to read your books and play videos—the things you enjoy?''
Tolans appear cute and goofy, but the idea behind them—that AI systems should be designed with human psychology and wellbeing in mind—is worth taking seriously.
A growing body of research shows that many users turn to chatbots for emotional needs, and the interactions can sometimes prove problematic for peoples' mental health. Discouraging extended use and dependency may be something that other AI tools should adopt.
Companies like Replika and Character.ai offer AI companions that allow for more romantic and sexual role play than mainstream chatbots. How this might affect a user's wellbeing is still unclear, but Character.ai is being sued after one of its users died by suicide.
Chatbots can also irk users in surprising ways. Last April, OpenAI said it would modify its models to reduce their so-called sycophancy, or a tendency to be 'overly flattering or agreeable', which the company said could be 'uncomfortable, unsettling, and cause distress.'
Last week, Anthropic, the company behind the chatbot Claude, disclosed that 2.9 percent of interactions involve users seeking to fulfill some psychological need such as seeking advice, companionship, or romantic role-play.
Anthropic did not look at more extreme behaviors like delusional ideas or conspiracy theories, but the company says the topics warrant further study. I tend to agree. Over the past year, I have received numerous emails and DMs from people wanting to tell me about conspiracies involving popular AI chatbots.
Tolans are designed to address at least some of these issues. Lily Doyle, a founding researcher at Portolo, has conducted user research to see how interacting with the chatbot affects users' wellbeing and behavior. In a study of 602 Tolan users, she says 72.5 percent agreed with the statement 'My Tolan has helped me manage or improve a relationship in my life.'
Farmer, Portolo's CEO, says Tolans are built on commercial AI models but incorporate additional features on top. The company has recently been exploring how memory affects the user experience, and has concluded that Tolans, like humans, sometimes need to forget. 'It's actually uncanny for the Tolan to remember everything you've ever sent to it,' Farmer says.
I don't know if Portolo's aliens are the ideal way to interact with AI. I find my Tolan quite charming and relatively harmless, but it certainly pushes some emotional buttons. Ultimately users are building bonds with characters that are simulating emotions, and that might disappear if the company does not succeed. But at least Portolo is trying to address the way AI companions can mess with our emotions. That probably shouldn't be such an alien idea.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Los Angeles Times
19 hours ago
- Los Angeles Times
Zero-G Biology
El Segundo-based Varda Space Industries is using space-based technology to manufacture complex pharmaceuticals in orbit, leveraging microgravity to create unique drug formulations for clients. — An El Segundo company has a novel solution to creating complex pharmaceuticals – using space tech to launch them into orbit The next frontier for medicine is closer to Los Angeles than San Francisco but feels like another galaxy. That's because it's about 300 miles straight up above sea level – in low-Earth orbit. Varda Space Industries, an El Segundo microgravity-enabled life sciences company, uses low-Earth orbit to develop unique drug formulations. It's a space-age approach to medicine that launches a capsule containing chemical compounds beyond Earth's atmosphere, where microgravity allows pharmaceutical formulations to be created in a process differently than on the surface. The capsules then reenter the atmosphere with their precious cargo. It became the first company to complete a manufacturing mission conducted outside of the International Space Station last year. Two more missions followed in early 2025 and a fourth launched on June 22. Varda plans to launch one more capsule this year and has four scheduled in 2026, which are all booked to capacity. 'What's special about next year is that the last two capsules will be going up on the same rocket. It will be the first time where we have two spacecraft in orbit at once, and we'll start to move into a fleet mentality,' said Will Bruey, chief executive and co-founder of Varda. Bruey, a former SpaceX engineer co-founded the company in 2021 with Delian Asparouhov, a former principal at Khosla Ventures. The company's growth is supported by a new round of investment. In July, the company announced a $187-million Series C round led by Natural Capital and Shrug Capital, with participation from Founders Fund, Peter Thiel, Khosla Ventures, Caffeinated Capital, Lux Capital and Also Capital. That brings total funding to $329 million. It will use the additional funds to scale operations so that it an expand its capsule production capacity, as well as open additional ground test facilities for pharmaceutical development. Additional capacity could eventually help lower costs – the average mission costs several million dollars today, although the finances are not measured by traditional revenue figures because there is potential to structure deals with royalties from the research and development conducted now. To support its additional manufacturing capabilities, it signed a 10,000-square-foot lease near its El Segundo headquarters for a dedicated lab space that will design molecules and test them prior to launch. The new laboratory will facilitate more complex experiments and allow it to research small molecules and move into more complex biologics. It currently has roughly 130 employees, and that number could increase to 180 within the next 12 months. Bruey envisions a time when there is a steady stream of capsules launching into, and returning from, space for biotech research, with launches on a weekly or daily basis. The company envisions scaling operations by launching more frequently, rather than trying to increase the size of their capsules to accommodate more experiments at a single launch. He likened it to his first job as a pizza delivery driver where the goal was to deliver many pizzas hot and fast to a large number of customers rather than waiting for a large order that required a semitruck to make the delivery. The capsules and satellite buses that carry them are constructed at the company's 61,000-square-foot headquarters where it forges raw materials into space vehicles. Those are then transported to Vandenberg Space Force Base up the coast near Santa Barbara for launch aboard a SpaceX rocket. Reusable rockets have lowered the cost of access to space and opened a range of in-space activities. Increased launch capabilities from companies, such as Long Beach-based Relativity Space, could lower costs even further as the lower-earth-orbit economy becomes more attainable as a destination for manufacturing, biotech, data centers and other technologies. Inside of the Varda capsule, custom-made lab equipment holds raw components that are mixed to form the targeted chemical compound. The device itself is small – measuring less than two feet tall by one foot wide. It has proprietary technology that is different from lab equipment on Earth. For example, a gas bubble that forms during an experiment on Earth would escape due to gravity, but it's not able to do so in space, so the equipment needs to account for environmental factors. Molecules could take a day or more to form, so the capsule remains in space for an extended period of time to complete the experiment. It also must preserve the temperature during re-entry and secure it from vibrations to ensure that the molecule is not destroyed. The capsule re-enters the atmosphere at speeds that reach Mach 25. Re-entry is supervised at the company's mission control center inside the headquarters building, where teams oversee both the capsule re-entry and its novel cargo. The capsule acts like a hypersonic wind tunnel at top speeds, so Varda has secured contracts with NASA and the Department of Defense to test materials for other applications beyond pharmeceutical development. This is also a third line of business – microgravity testing on materials for government and private clients – similar to the way that experiments are conducted on the International Space Station but with full automation and with the results delivered faster and at a lower cost than waiting for transportation to and from the space station. The typical Varda mission can last about two months. Varda is the first and only company to receive a special vehicle operator license under FAA Part 450. The W-4 mission is the first time the agency has issued that license, which allows it to reenter W-series capsules as needed without submitting new safety methodologies to the FAA for each identical flight. It has permission from the FAA to reenter capsules through 2029 before needing to renew the license. The W-4 mission is the maiden flight for Varda's next-generation spacecraft, which includes an in-house platform to navigate the spacecraft during the mission. While in orbit, the satellite bus provides the capsule with power, communications, attitude control and propulsion. When the capsule is ready for re-entry, it separates from the satellite bus and reenters, where it is recovered. Several startups have conducted test flights, such as German firm Atmos Space Cargo, California-based Outpost Space and Inversion Space, but none of these companies have successfully launched and landed a commercial mission. Meanwhile, SpaceX is reportedly interested in developing similar biotech capabilities to Varda. In some ways, the competition has helped Varda by lending validity to its approach to the larger biotech community, which is taking greater interest due to more capacity and competition. 'More people are getting to see the huge opportunity. We're actually pretty excited,' said Bruey. 'We've collaborated with SpaceX the last five years. Our partnership right now is focused on the launch aspect, and we'll continue to collaborate.' In February, Colorado-based Sierra Space, a commercial space and defense company that is building the Dream Chaser spaceplane, announced initiatives to advance research and development of biopharmaceutical solutions in low-Earth orbit during its inaugural mission to the International Space Station. Plans include conducting experiments to identify new ways to deliver cancer therapies to patients on Earth in collaboration with Merck. Another challenge for Varda is companies that are developing commercial space stations, such as Axiom Space, Blue Origin and Starlab Space. While these are in current development, they still have several years before they could come online. 'Once the commercial space stations have real estate in space, they will sell capacity or manufacturing,' said Dr. Leon Alkalai, chief executive at Mandala Space Ventures (and an investor in Varda). However, Varda has a real advantage built in to its ethos. 'Rather than thinking of manufacturing as a service, Varda is making it part of their core competency and betting on the value-add component to make themselves part of the value chain.' Overall, the space economy currently generates $613 billion in revenue, according to a recent report from The Space Foundation, which tracks revenue and spending on space technology. It projects that the space economy could grow to $1 trillion by 2032 at the current growth rate. Asparouhov credited an experiment published by pharmaceutical developer Merck in 2019 regarding the International Space Station as inspiration for Varda. That experiment demonstrated microgravity could develop higher-quality and more uniform crystallization. The applications could lead to new drug formations or entirely new medicines. For example, there is potential for medication that needs to be given intravenously to be recalibrated into a shelf-stable pill format. The company focus is both a biotech formulation platform and a space operation. It doesn't discover the molecules or choose what targets to go after. Rather, its business is to work within the pharmaceutical supply chain during the manufacturing process to open formulations that wouldn't otherwise exist. In a sense, the Varda system is a specialized piece of lab equipment that can introduce a new type of environment for biotech research. Bruey likened it to the introduction of other technologies such as cold and refrigeration, which have major implications on drug development. Crystallization and growth continue on Earth following the initial microgravity development. It's akin to a sourdough starter, which can be expanded to many loaves of bread once it's initially formed. Crystallization processes are commonly used in the manufacture of small molecules and small protein therapeutics. However, it has been challenging to identify the optimal crystallization processes for biologic drugs due to their large size and the flexibility of their structure. Once the drugs are developed, they are still required to go through testing, clinical trials and would need regulatory approval. A traditional drug development timeline could take a decade on average, and Bruey stated that he hopes that Varda's initial microgravity molecules could be available by the end of the decade for commercial use. 'The partners that we have see us as a pharmaceutical company. They don't see us as a space company. They bring us a drug that is having a particular problem, and we go solve it for them and hand it back,' said Asparouhov.
New York Post
4 days ago
- New York Post
Man with ‘world's largest willy' slips, breaks arm in shower because giant penis got in the way: ‘It was a very embarrassing accident'
Being well-endowed isn't all it's cracked up to be. We've heard of people whose mammoth members have injured their partners. However, a UK man with the world's largest Johnson reportedly hurt himself after slipping and breaking his arm in the shower because his titanic tallywacker got in his way. 'It was a very embarrassing accident,' Matt Barr told Jam Press of the phallus-induced injury. Advertisement 4 Matt Barr, the man with the world's largest penis, reportedly slipped and broke his arm in the shower because his titanic tallywacker obstructed his view. Jam Press/Matt Barr The AI specialist frequently goes viral for his enormous unit, which, at 14.5 inches long, is reportedly the 'biggest medically proven penis in the world.' Barr even has a cast of his jumbo Johnson at the Phallological Museum in Iceland. A preternaturally big penis might sound like a blessing, but there are myriad downsides, including struggling to get dressed, feeling faint while erect and bizarre propositions, which he details in his book, 'A Long Story: Life With One Of The World's Largest Penises.' Advertisement It can even be quite dangerous, as Barr recently discovered during a disastrous trip to the shower. 'One of the issues with being so large, especially in hot water showers, is that it's not exactly easy to see my feet,' the London resident recalled. 'As I was rushing to get ready for work, I didn't see the excess shower gel in the tub because my penis was the only thing in my eye line.' 4 'I've had close calls or minor falls before, but never anything this severe,' said Barr, describing the accident Jam Press/Matt Barr He explained, 'I slipped on it, causing me to fall out of the tub completely headfirst and crack my shoulder on the hard floor.' Advertisement Shlong story short, the well-endowed Brit sustained 'two fractures,' which left him in excruciating pain and forced him to wear a sling. 'I've had close calls or minor falls before, but never anything this severe,' said Barr while reflecting on the accident. 'Usually, it's just been when I've had a partner in the shower with me.' He added, 'I've always been anxious about going into public showers because of the reactions I get, but now I'm a bit scared of private ones, too. 4 The well-endowed Brit sustained 'two fractures,' which left him in excruciating pain and forced him to wear a sling. Jam Press/Matt Barr Advertisement To help prevent future falls, Barr has resolved to 'shower less quickly.' He also bought a bathmat so he's less likely to lose his footing even with his penis obstructing his view. 'This is one of the many minor things no one thinks about when it comes to having an abnormal body,' lamented Barr, who has since healed from his injury. 'While I'm naturally clumsy, it doesn't help that I have a different anatomy to most – especially such a large one.' Prior to the accident, the Brit had hoped to embark on a seaside getaway — but decided to cancel after the fall. However, that may not be a bad decision given previous embarrassing seaside ordeals that Barr has experienced as a result of his behemoth bulge. The AI expert recalled one embarrassing incident at a resort, where the manager asked him to leave the pool area because of the mammoth outline in his trunks. It was reportedly visible despite the fact that he was wearing dark board shorts with compression shorts underneath to prevent said impromptu peep show. 'I won't go on a standard package holiday or in an all-inclusive resort hotel pool, but it's helped me to look further afield and find quieter locations,' he said. 'It's not really such a big deal, though. Just another thing I'm unable to do.' Advertisement 4 A plaster cast of Barr's massive phallus at the Phallological Museum in Iceland. Jam Press The issues aren't just physical either, according to Barr, who says he's received some bizarre propositions. He recalled one bizarre instance where a guy asked to draw him in 'cartoon form as a giant and do all this sex giant sex stuff' — a fetish known as macrophilia. Due to his age, the Brit says he has no plans to cash in on his awe-inspiring anatomy via OnlyFans, as he might have were he half his age, explaining: 'I'm sure if I was 20 years younger, I would have [because] I'd be more focused on making sure my parents were all good, I'd be in the gym constantly, all these things.'
Yahoo
4 days ago
- Yahoo
Half of Gen Z workers want ‘growth mindset' jobs in AI era
This story was originally published on HR Dive. To receive daily news and insights, subscribe to our free daily HR Dive newsletter. As young workers face competition with artificial intelligence tools for entry-level work, 52% of Generation Z job seekers say they're prioritizing 'growth mindset' roles that offer personal development opportunities, according to an August report from Flexa. In particular, Gen Z workers are 68% more likely to prioritize learning and development benefits — such as language lessons, mentor programs and study leave — when seeking new jobs, as compared to a third of millennials, Generation X and baby boomers. ''Growth mindset' jobs that offer opportunities for personal development have become increasingly important for Gen Z as they enter a very challenging job market,' Molly Johnson-Jones, co-founder and CEO of Flexa, said in a statement. 'Of all working-age generations, Gen Z is most comfortable with the AI tools that are both taking away work and creating new opportunities,' Johnson-Jones said. 'But with AI taking on the burden of low-level, repetitive tasks, the nature of roles available to job seekers entering the workforce for the first time is changing.' Overall, job seekers increasingly expect skill-building opportunities and continuous learning from their employers, and more than a quarter have left a job due to a lack of skill development, according to an Aerotek report. Employers who invest in training 'will be best positioned to attract and retain top talent' amid workplace changes, an Aerotek executive said. In a survey of nearly 30,000 job seekers and insights from more than 40,000 job posts, Flexa reported a 240% increase in the number of job searches for roles offering learning and development benefits since the start of 2025 — across all age groups. In addition, since January, 64% of job postings have advertised learning and development opportunities, which could include personal development days, coaching programs and study sabbaticals, Flexa found. Without growth, workers may feel left behind. More than 20% of U.S. workers believe their professional future is out of their hands and they have worse control than five years ago, according to a report from the University of Phoenix Career Institute. Workers were 52% more likely to experience burnout when they felt they weren't progressing. However, they named career development as one of the top ways to restore their sense of control and reduce burnout.
